Amphastar Pharma | Business Contracts

Supply Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Letop Biotechnology Co., Ltd. dated November 15, 2022 (Filed With SEC on November 18, 2022)

Contract Research Agreement by and between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated July 5, 2022 (Filed With SEC on November 8, 2022)

Share Repurchase Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc., Nanjing Qianqia Enterprise Management Consulting (LLP), Nanjing Zhongpan Enterprise Management... (Filed With SEC on August 9, 2021)

Separation Agreement and General Release of Claims by and between the Company and Jason Shandell dated as of April 13, 2020 (Filed With SEC on August 10, 2020)

Contract Manufacturing Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated April 19, 2022 (Filed With SEC on August 9, 2022)

Share Purchase Agreement by and between Amphastar Pharmaceuticals, Inc., Nanjing Zhongpan Enterprise Management Consulting Center (LLP), Nanjing Zhanrun Enterprise Management... (Filed With SEC on August 9, 2021)

Sixth Amendment to the Supply Agreement by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc., dated May 24, 2021 (Filed With SEC on August 9, 2021)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 15, 2021)

Eight Modification to the Revolving Line of Credit Agreement, dated March 7, 2016, between International Medication Systems, Limited and East West Bank in the principal sum of... (Filed With SEC on March 15, 2021)

Equipment Line of Credit, dated September 1, 2020, between International Medication Systems, Limited and East West Bank in the original sum of $10,000,000 (Filed With SEC on November 6, 2020)

Eighth Modification to the Revolving Line of Credit Agreement, dated June 15, 2020, between Amphastar Pharmaceuticals, Inc. and Armstrong Pharmaceuticals, Inc. and Cathay Bank in... (Filed With SEC on August 10, 2020)

Amphastar Pharmaceuticals, Inc. Employee Deferred Compensation Plan, effective December 1, 2019 (Filed With SEC on March 16, 2020)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 16, 2020)

Ninth Amendment to the Acquisition Loan, dated July 19, 2019 between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on August 9, 2019)

Fifth Amendment to the Supply Agreement by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc., dated August 2, 2019 (Filed With SEC on August 9, 2019)

First Modification to the Loan Agreement, dated April 22, 2019, between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on May 10, 2019)

Equipment Line of Credit, dated January 8, 2019, between International Medication Systems, Limited and East West Bank in the original principal sum of $10,000,000 (Filed With SEC on May 10, 2019)

Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc (Filed With SEC on March 15, 2019)

Amphastar Pharma (18)